Home › Trial NCT07833852
Long-Term Immune Persistence After Bivalent HPV Vaccination in Females From Study 311-HPV-1005
- Trial IDNCT07833852
- StatusEnrolling By Invitation
- PhaseN/A
- Study typeObservational
- SponsorShanghai Zerun Biotechnology Co.,Ltd
- Enrollment486
- Start date2024-08-30
- ConditionsHuman Papillomavirus Infection · Cervical Intraepithelial Neoplasia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.